Search

Lakshmi Sarada Channavajjala

Examiner (ID: 456, Phone: (571)272-0591 , Office: P/1611 )

Most Active Art Unit
1611
Art Unit(s)
1615, 1611
Total Applications
1737
Issued Applications
722
Pending Applications
210
Abandoned Applications
818

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17944237 [patent_doc_number] => 20220331254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => PELLET AND MULTI-UNIT PELLET SYSTEM (MUPS) [patent_app_type] => utility [patent_app_number] => 17/856817 [patent_app_country] => US [patent_app_date] => 2022-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5884 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17856817 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/856817
PELLET AND MULTI-UNIT PELLET SYSTEM (MUPS) Jun 30, 2022 Abandoned
Array ( [id] => 17928223 [patent_doc_number] => 20220323348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-13 [patent_title] => LOZENGE [patent_app_type] => utility [patent_app_number] => 17/809288 [patent_app_country] => US [patent_app_date] => 2022-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2352 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17809288 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/809288
LOZENGE Jun 27, 2022 Abandoned
Array ( [id] => 18257968 [patent_doc_number] => 20230085008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => PHARMACEUTICAL COMPOSITIONS OF MIFEPRISTONE [patent_app_type] => utility [patent_app_number] => 17/843669 [patent_app_country] => US [patent_app_date] => 2022-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17403 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17843669 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/843669
Pharmaceutical compositions of mifepristone Jun 16, 2022 Issued
Array ( [id] => 20577208 [patent_doc_number] => 12569443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-10 [patent_title] => Gastro-retentive drug delivery system [patent_app_type] => utility [patent_app_number] => 17/833979 [patent_app_country] => US [patent_app_date] => 2022-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 8720 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833979 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/833979
Gastro-retentive drug delivery system Jun 6, 2022 Issued
Array ( [id] => 17836268 [patent_doc_number] => 20220273573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => SOLID DISPERSION GENISTEIN COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/664015 [patent_app_country] => US [patent_app_date] => 2022-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8059 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17664015 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/664015
SOLID DISPERSION GENISTEIN COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME May 17, 2022 Pending
Array ( [id] => 20270699 [patent_doc_number] => 12440463 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-14 [patent_title] => Modified release orally administered amino acid formulations [patent_app_type] => utility [patent_app_number] => 17/660999 [patent_app_country] => US [patent_app_date] => 2022-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 19 [patent_no_of_words] => 17265 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 266 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17660999 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/660999
Modified release orally administered amino acid formulations Apr 26, 2022 Issued
Array ( [id] => 20676397 [patent_doc_number] => 20260115206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-04-30 [patent_title] => 3Alpha-OH-5Alpha-Pregnan-20-One Compositions and Methods for Treating CNS Disorders [patent_app_type] => utility [patent_app_number] => 17/723203 [patent_app_country] => US [patent_app_date] => 2022-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30115 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17723203 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/723203
3Alpha-OH-5Alpha-Pregnan-20-One Compositions and Methods for Treating CNS Disorders Apr 17, 2022 Pending
Array ( [id] => 17747411 [patent_doc_number] => 20220225614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => SYNERGISTIC DISINFECTANT COMPOSITIONS HAVING ENHANCED ANTIMICROBIAL EFFICACY AND STABILITY, AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/714178 [patent_app_country] => US [patent_app_date] => 2022-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11280 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714178 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/714178
Synergistic disinfectant compositions having enhanced antimicrobial efficacy and stability, and methods of using the same Apr 5, 2022 Issued
Array ( [id] => 17895297 [patent_doc_number] => 20220304959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => TREATMENT OF LONG HAULERS SYNDROME WITH NICLOSAMIDE [patent_app_type] => utility [patent_app_number] => 17/703626 [patent_app_country] => US [patent_app_date] => 2022-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41995 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17703626 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/703626
TREATMENT OF LONG HAULERS SYNDROME WITH NICLOSAMIDE Mar 23, 2022 Abandoned
Array ( [id] => 18483633 [patent_doc_number] => 20230210934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => LYCIUM BARBARUM LEAF POLYSACCHARIDE RICH IN GALACTURONIC ACID AND PREPARATION METHOD AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/652210 [patent_app_country] => US [patent_app_date] => 2022-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4430 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17652210 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/652210
LYCIUM BARBARUM LEAF POLYSACCHARIDE RICH IN GALACTURONIC ACID AND PREPARATION METHOD AND USE THEREOF Feb 22, 2022 Abandoned
Array ( [id] => 20525998 [patent_doc_number] => 12544417 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-10 [patent_title] => Oral film and stick jelly for improving absorption in the oral mucosa, antioxidant activity, anti-inflammatory activity, and liver function of humans and companion animals [patent_app_type] => utility [patent_app_number] => 17/769051 [patent_app_country] => US [patent_app_date] => 2022-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6942 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769051 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/769051
Oral film and stick jelly for improving absorption in the oral mucosa, antioxidant activity, anti-inflammatory activity, and liver function of humans and companion animals Feb 16, 2022 Issued
Array ( [id] => 20401268 [patent_doc_number] => 12491228 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-09 [patent_title] => Fine bamboo powder and preparation method therefor and use thereof [patent_app_type] => utility [patent_app_number] => 17/589963 [patent_app_country] => US [patent_app_date] => 2022-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 14381 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 250 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17589963 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/589963
Fine bamboo powder and preparation method therefor and use thereof Jan 31, 2022 Issued
Array ( [id] => 18244372 [patent_doc_number] => 20230076683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-09 [patent_title] => Controlled Release Formulations and Methods of Targeted Drug Delivery within the Small Intestine Wall [patent_app_type] => utility [patent_app_number] => 17/562899 [patent_app_country] => US [patent_app_date] => 2021-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16420 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 206 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17562899 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/562899
Controlled Release Formulations and Methods of Targeted Drug Delivery within the Small Intestine Wall Dec 26, 2021 Abandoned
Array ( [id] => 17532306 [patent_doc_number] => 20220110915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-14 [patent_title] => EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION [patent_app_type] => utility [patent_app_number] => 17/560493 [patent_app_country] => US [patent_app_date] => 2021-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12038 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17560493 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/560493
Edaravone suspension for oral administration Dec 22, 2021 Issued
Array ( [id] => 19700150 [patent_doc_number] => 12194150 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-14 [patent_title] => Levodopa dosing regimen [patent_app_type] => utility [patent_app_number] => 17/558337 [patent_app_country] => US [patent_app_date] => 2021-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 39730 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 251 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17558337 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/558337
Levodopa dosing regimen Dec 20, 2021 Issued
Array ( [id] => 17519216 [patent_doc_number] => 20220105064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER [patent_app_type] => utility [patent_app_number] => 17/553367 [patent_app_country] => US [patent_app_date] => 2021-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20238 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17553367 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/553367
CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER Dec 15, 2021 Abandoned
Array ( [id] => 18842668 [patent_doc_number] => 20230405072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => Texture-Controlled Fiber Ingredient Containing Viscous Soluble Fiber and Consumable Food and Fiber Supplement Products Incorporating Same [patent_app_type] => utility [patent_app_number] => 18/037611 [patent_app_country] => US [patent_app_date] => 2021-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11810 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18037611 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/037611
Texture-Controlled Fiber Ingredient Containing Viscous Soluble Fiber and Consumable Food and Fiber Supplement Products Incorporating Same Nov 18, 2021 Pending
Array ( [id] => 18842664 [patent_doc_number] => 20230405068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => RADIATION-INDUCED FIBROSIS TREATMENT [patent_app_type] => utility [patent_app_number] => 18/035432 [patent_app_country] => US [patent_app_date] => 2021-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7348 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035432 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/035432
RADIATION-INDUCED FIBROSIS TREATMENT Nov 7, 2021 Pending
Array ( [id] => 19622972 [patent_doc_number] => 12161764 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-10 [patent_title] => Composition and methods of treatment [patent_app_type] => utility [patent_app_number] => 17/512139 [patent_app_country] => US [patent_app_date] => 2021-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 8398 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17512139 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/512139
Composition and methods of treatment Oct 26, 2021 Issued
Array ( [id] => 17881112 [patent_doc_number] => 20220296589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => Formulations of 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, Taste-Modified Formulations, and Methods of Making and Using Same [patent_app_type] => utility [patent_app_number] => 17/509965 [patent_app_country] => US [patent_app_date] => 2021-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41557 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17509965 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/509965
Formulations of 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, Taste-Modified Formulations, and Methods of Making and Using Same Oct 24, 2021 Abandoned
Menu